# OnCo record vnx-201 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/vnx-201/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "vnx-201" ;
  schema:name "VNX-201"@en ;
  schema:description "VNX-201 is an experimental in vivo gene therapy from Vironexis Biotherapeutics, in preclinical development for GD2-positive neuroblastoma."@en ;
  schema:url <https://onco.cc/drugs/vnx-201/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://vironexis.com> ;
  onco:status "preclinical" ;
  onco:tag "pipeline" ;
  onco:modality "In vivo gene therapy (TransJoin vectorised T-cell engager)" ;
  onco:targets <https://onco.cc/targets/gd2/> ;
  onco:companies <https://onco.cc/companies/vironexis-biotherapeutics/> .